Title : 5-HT2c agonist, lorcaserin, reduces aggressive responding in intermittent explosive disorder: A pilot study.

Pub. Date : 2019 Nov

PMID : 31774584






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 5-HT2c agonist, lorcaserin, reduces aggressive responding in intermittent explosive disorder: A pilot study. lorcaserin 5-hydroxytryptamine receptor 2C Homo sapiens
2 OBJECTIVES: To test the hypothesis that pretreatment with the selective 5-HT2c agonist, lorcaserin, can reduce aggressive responding in impulsively aggressive individuals. lorcaserin 5-hydroxytryptamine receptor 2C Homo sapiens